The therapy works by delivering precisely timed electrical pulses to the heart and can be used alongside other heart failure medications and therapies. It’s meant for heart failure patients who are no longer responding to medications meant to manage symptoms or slow progression.
Ivan Cakulev, MD, medical director of ambulatory cardiac telemetry at UH Cleveland Medical Center performed Northeast Ohio’s first CCM therapy device procedure in May, according to a June 22 news release.
To learn more, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.